The Latest Breaking News from FDA

Samsung's sleep apnea feature on the Galaxy Watch has received FDA authorization, allowing users to detect signs of sleep apnea and seek medical care.

J.P. Morgan thinks sales of weight-loss drugs could exceed $100 billion by 2030. That's good news for Eli Lilly, which is now the largest pharma company by market capitalization and the 9th-biggest S&P 500 stock. Here's why LLY stock looks poised to put on even more weight in the months…

Samsung's Galaxy Watch will be able to detect signs of sleep apnea in the U.S. as the FDA gives its approval.

Given the growing demand for healthcare facilities, rapid integration of digital technology, and transformative biotechnology breakthroughs, the medical industry is poised for continued growth and profitability this year and beyond. Amid this, let’s find out why investors are flocking to medical stocks Vertex Pharmaceuticals (VRTX) and McKesson (MCK). Read more….

A research paper that raises questions about the safety of abortion has been retracted. The research is cited in a federal judge's ruling about the abortion pill mifepristone.

Cytokinetics has shucked off two high-profile setbacks, leading CYTK stock to double as it looks to take on Bristol in heart disease.

“I hope that this will make people more careful about when they cite studies," one lawyer told Salon

In 2024, the FDA will decide whether or not MDMA can be used to treat patients suffering from PTSD.

The myriad potential harms of these products are wide-ranging

The FDA will soon move to ban formaldehyde in hair-straightening products. It's more than a decade after research raised alarms about health risks and other worrying chemicals remain in the products.

“The Maharashtra Food and Drug Administration (FDA) has exposed a bogus medicine racket and seized 21,600 tablets that had been passed off as ‘antibiotic ciprofloxacin’ from a government hospital in Nagpur,” an official said.